SCHEMBL2851675

SCHEMBL2851675

CCCCc1ccc(C#Cc2ccc(CN(C(=O)CCC3CCCC3)c3cc(C(=O)OCC)ccc3F)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.36
PTGDR2 Q9Y5Y4 4/20 0.36
PTPN11 Q06124 1/20 0.35
PTPRO Q16827 1/20 0.35
ACACB O00763 2/20 0.35
MGLL Q99685 2/20 0.35
FAAH O00519 1/20 0.35
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
LTB4R2 Q9NPC1 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HTR5A P47898 1/20 0.33
SLC6A4 P31645 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13513443 0.93 LTB4R2 (0.40) CNR2PTGDR2DRD2DRD3HDAC3
SCHEMBL2853040 0.91 LTB4R2 (0.40) CNR2PTGDR2PTPN11PTPROMGLL
SCHEMBL2860171 0.87 NR1H4 (0.40) CNR2PTPN11PTPRODRD2DRD3
SCHEMBL13711657 0.83 LTB4R2 (0.48) PTGDR2DRD2DRD3LTB4R2ALDH1A1
SCHEMBL2859097 0.81 PTPN11 (0.42) CNR2PTPN11PTPRODRD2DRD3
SCHEMBL2853693 0.80 PTPN11 (0.41) CNR2PTPN11PTPRODRD2DRD3
SCHEMBL1734720 0.79 PTPN11 (0.50) PTPN11PTPROLTB4R2
SCHEMBL2851668 0.79 LTB4R2 (0.51) CNR2PTPN11PTPROLTB4R2SLC6A4
SCHEMBL13711777 0.79 LTB4R2 (0.48) DRD2DRD3LTB4R2HTR5ASLC6A4
SCHEMBL1734722 0.78 PTPN11 (0.49) PTPN11PTPROLTB4R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1654247-B1 ALKYNYL ARYL CARBOXAMIDES MERCK SERONO SA (CH) 2010-01-20 EP disclosed
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US disclosed
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed
EP-1654247-A1 ALKYNYL ARYL CARBOXAMIDES Applied Research Systems ARS Holding N.V. (AN) 2006-05-10 EP disclosed
WO-2005012280-A1 ALKYNYL ARYL CARBOXAMIDES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105913-A1 Alkynyl aryl carboxamides ECHS1, IRS1, HCCS CNR2 198/4885PTGDR2 1779/4885PTPN11 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.